Results 171 to 180 of about 20,782 (204)
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen. [PDF]
EBioMedicineFerreira RC, Reynolds SJ, Capoferri AA, Baker OR, Brown EE, Klock E, Miller J, Lai J, Saraf S, Kirby C, Lynch B, Hackman J, Gowanlock SN, Tomusange S, Jamiru S, Anok A, Kityamuweesi T, Buule P, Bruno D, Martens C, Rose R, Lamers SL, Galiwango RM, Poon AFY, Quinn TC, Prodger JL, Redd AD. +26 moreeuropepmc +1 more sourceCorrigendum to: Clinical Effectiveness of Integrase Strand Transfer Inhibitor–Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada
Haidong Lu, Stephen R. Cole, Daniel Westreich, Michael G. Hudgens, Adaora A. Adimora, Keri N. Althoff, Michael J. Silverberg, Kate Buchacz, Jun Li, Jessie K. Edwards, Peter F. Rebeiro, Viviane D. Lima, Vincent C. Marconi, Timothy R. Sterling, Michael A. Horberg, M. John Gill, Mari M Kitahata, Joseph J. Eron, Richard D Moore +18 moreopenalex +1 more sourceNew 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase—Discovery of a new polyhydroxylated antiviral agent
, 2010 Cédric Maurin, Cédric Lion, Fabrice Bailly, Nadia Touati, Hervé Vezin, Gladys Mbemba, Jean François Mouscadet, Zeger Debyser, Myriam Witvrouw, Philippe Cotelle +9 moreopenalex +2 more sourcesIntegration of Longitudinal Metabolome and Lipidome Changes Associated With Weight Gain in Women With HIV After Integrase Strand Transfer Inhibitor Initiation – A Pilot Study
Chihae Yang, Sami Teeny, C Christina Mehta, Qian Yang, Tsungirirai Maramba, Igho Ofotokun, Anandi N. Sheth, Kristal Maner-Smith, Mohammed K. Ali, Dean P. Jones, Young‐Mi Go, Thomas R. Ziegler, Cecile D. Lahiri, Jessica A. Alvarez +13 moreopenalex +1 more source